We are live on ! Find out more
NGNE icon

Neurogene

55 hedge funds and large institutions have $241M invested in Neurogene in 2019 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

349% more capital invested

Capital invested by funds: $53.7M → $241M (+$188M)

190% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 10

53% more funds holding

Funds holding: 3655 (+19)

23% more call options, than puts

Call options by funds: $777K | Put options by funds: $632K

1.33% less ownership

Funds ownership: 3.35%2.01% (-1.3%)

31% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 13

Holders
55
Holders Change
+19
Holders Change %
+52.78%
% of All Funds
1.08%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
29
Increased
9
Reduced
13
Closed
10
Calls
$777K
Puts
$632K
Net Calls
+$145K
Net Calls Change
+$144K
Name Holding Trade Value Shares
Change
Change in
Stake
SCM
26
Sio Capital Management
New York
$1.09M +$439K +4,409 New
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$700K
Northern Trust
28
Northern Trust
Illinois
$675K +$40.9K +411 +18%
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$621K -$253K -2,541 -50%
Millennium Management
30
Millennium Management
New York
$587K -$1.8M -18,078 -88%
LGM
31
Logos Global Management
California
$499K +$202K +2,026 New
Stifel Financial
32
Stifel Financial
Missouri
$472K +$193K +1,934 New
JG
33
Jefferies Group
New York
$400K +$162K +1,625 New
Alyeska Investment Group
34
Alyeska Investment Group
Illinois
$354K +$143K +1,437 New
Arrowstreet Capital
35
Arrowstreet Capital
Massachusetts
$352K +$142K +1,429 New
Two Sigma Advisers
36
Two Sigma Advisers
New York
$330K -$57.8K -580 -30%
CSS
37
Cubist Systematic Strategies
Connecticut
$268K +$108K +1,087 New
Bank of New York Mellon
38
Bank of New York Mellon
New York
$195K -$3.09K -31 -4%
Goldman Sachs
39
Goldman Sachs
New York
$189K +$76.2K +765 New
ARTA
40
A.R.T. Advisors
New York
$188K +$75.8K +761 New
NFC
41
Northeast Financial Consultants
Connecticut
$185K -$117K -1,170 -61%
BBVA
42
Banco Bilbao Vizcaya Argentaria
Spain
$182K +$74.7K +750 New
KM
43
Kalos Management
Georgia
$177K -$1.69K -17 -2%
Charles Schwab
44
Charles Schwab
California
$174K +$70K +703 New
AC
45
Aristides Capital
Kentucky
$171K +$69.2K +695 New
AGM
46
Alpine Global Management
New York
$170K +$68.6K +689 New
Two Sigma Investments
47
Two Sigma Investments
New York
$169K -$262K -2,633 -79%
State Street
48
State Street
Massachusetts
$150K
Janus Henderson Group
49
Janus Henderson Group
United Kingdom
$146K +$58.9K +591 New
RJFSA
50
Raymond James Financial Services Advisors
Florida
$125K +$50.7K +509 New

NGNE Hedge Fund Activity: Q4 2019 in Review

55 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q4 2019, worth a combined $241M — up 349% from $53.7M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new NGNE positions and 10 closed out — a net gain of 19 holders — while 9 added to existing stakes and 13 trimmed.

The largest buyer was Redmile Group, opening a new position worth an estimated $9.57M. The largest seller was Baker Bros. Advisors, cutting an estimated $39.4M.

  • 55 institutional investors held Neurogene (NGNE) as of Q4 2019, up from 36 in Q3 2019.
  • Funds reported $241M of Neurogene stock for Q4 2019, up 349% quarter-over-quarter.
  • 29 funds opened new Neurogene positions in Q4 2019 and 10 closed out, a net change of +19 holders.
  • The largest Neurogene buyer in Q4 2019 was Redmile Group, an estimated $9.57M added.
  • The largest Neurogene seller in Q4 2019 was Baker Bros. Advisors, an estimated $39.4M sold.

Based on aggregated 13F filings for Q4 2019.